| 中文名 | GNF2133抑制剂 |
|---|---|
| 英文名 | GNF2133 |
| 中文别名 | 4-乙基-N-(4-(1-(四氢-2H-吡喃-4-基)-1H-吡咯并[2,3-C]吡啶-3-基)吡啶-2-基)哌嗪-1-甲酰胺 |
| 英文别名 |
4-Ethyl-N-(4-(1-(tetrahydro-2H-pyran-4-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl)pyridin-2-yl)piperazine-1-cboxamide
GNF2133, 10 mM in DMSO β-cell,RIP-DTA mice,Inhibitor,insulin secretion,GNF2133,inhibit,Dual specificity tyrosine regulated kinase,glucose disposal,Dual specificity tyrosine phosphorylation regulated kinase,CD-1 mice,GNF 2133,DYRK,GNF-2133,orally active 4-ethyl-N-{4-[1-(oxan-4-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]pyridin-2-yl}piperazine-1-cboxamide 1-Piperazinecboxamide, 4-ethyl-N-[4-[1-(tetrahydro-2H-pyran-4-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-2-pyridinyl] |
| 描述 | GNF2133是一种选择性DYRK1A抑制剂,IC50值为6 nM。 |
|---|---|
| 相关类别 | |
| 参考文献 |
| 分子式 | C24H30N6O2 |
|---|---|
| 分子量 | 434.53 |
| 储存条件 | 2-8°C,密封,干燥 |